Evolent Health, Inc.

Services-Management Services

EVH Business & Professional Services People in Business & Professional Services SEC CIK 0001628908 ↗

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Market capitalisation
$473.72M
113,059,335 shares Covers every share class this company has on file.
Insiders on file
6
people who have filed Form 3, 4 or 5 naming this issuer
Value of insider-held stock
$10.61M
from the holdings reported on Forms 3/4/5; this figure has no separate as-of date on file
Insider-held share of market cap
2.24%
insider-held value divided by market capitalisation

What Evolent Health, Inc. reports

Revenue and net income below are for fiscal period FY2025, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.

Revenue
$1.88B
FY2025 annual revenue, from this company’s own annual XBRL filings to the SEC
Net income
-$579.40M
FY2025 a loss for the period, from this company’s own annual XBRL filings to the SEC
Employees
4,200
Yahoo Finance
Where the employee count comes from

Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.

Insiders at Evolent Health, Inc.

Shares is what each person last reported holding here.

Everyone below has filed at least one insider report against this company.

Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.

Rows are grouped by the role each person reports.

The role comes from the relationship boxes a person ticks on their own insider filings — officer, director, ten per cent owner — not from anything we infer. Somebody who is both an officer and a director appears once, in the combined group, so the row count still matches the figure at the top of this page. Where no filing states a role we say so instead of guessing one.

People who file insider reports against Evolent Health, Inc..
Insider Reported role Shares Value Last action
Officers 4
Mario Ramos Mario Ramos CFO 587,500 $2.54M A Grant or award Jan 2, 2026 position reported
Daniel Joseph McCarthy President 423,022 $1.83M S Open-market sale Aug 26, 2026 position reported
John Paul Johnson John Paul Johnson CFO 309,245 $1.34M A Grant or award Jul 1, 2025 position reported
Jonathan Weinberg Jonathan Weinberg General Counsel 244,512 $1.06M F Shares withheld for taxes Jul 1, 2026 position reported
Officers who also sit on the board 1
Seth Blackley Seth Blackley CEO 836,962 $3.62M F Shares withheld for taxes Jul 1, 2026 position reported
Directors 1
Craig A Barbarosh Craig A Barbarosh Board Member 53,935 $233.0K A Grant or award Jun 4, 2026 position reported

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

3 insiders bought Evolent Health, Inc. (EVH) shares worth $614,668 on Mar 6, 2025

Cluster buying

3 different insiders made 3 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

3 insiders bought Evolent Health, Inc. (EVH) shares worth $614,668 on Mar 6, 2025
Date Insider Transaction Shares Price Value Filing
Mar 6, 2025 Craig A Barbarosh P Open-market purchase 2,000 held after: 31,956 $8.81 $17,620 SEC filing ↗
Mar 6, 2025 Seth Blackley P Open-market purchase 55,225 held after: 762,217 $9.01 $497,577 SEC filing ↗
Mar 6, 2025 Daniel Joseph McCarthy P Open-market purchase 11,040 held after: 389,004 $9.01 $99,470 SEC filing ↗

Total of the rows above: $614,668, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Recent insider transactions

Of the 60 rows we hold, 3 are open-market purchases (P) and 9 open-market sales (S) — the only codes we count as buying or selling.

The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.

A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.

Insider transactions disclosed to the SEC for Evolent Health, Inc., newest first, each with the filing behind it.
Date Insider Transaction Shares Price Value Filing
Aug 26, 2026 Daniel Joseph McCarthy S Open-market sale 65,892 $5.00 $329.5K SEC filing ↗
Jul 1, 2026 Jonathan Weinberg F Shares withheld for taxes 2,650 $5.74 $15.2K SEC filing ↗
Jul 1, 2026 Jonathan Weinberg A Grant or award 43,055 $0.00 $0 SEC filing ↗
Jul 1, 2026 Seth Blackley F Shares withheld for taxes 10,297 $5.74 $59.1K SEC filing ↗
Jul 1, 2026 Seth Blackley A Grant or award 446,102 $0.00 $0 SEC filing ↗
Jul 1, 2026 Daniel Joseph McCarthy F Shares withheld for taxes 4,582 $5.74 $26.3K SEC filing ↗
Jul 1, 2026 Daniel Joseph McCarthy A Grant or award 302,585 $0.00 $0 SEC filing ↗
Jun 4, 2026 Craig A Barbarosh A Grant or award 41,096 $0.00 $0 SEC filing ↗
Mar 3, 2026 Daniel Joseph McCarthy F Shares withheld for taxes 24,027 $3.51 $84.3K SEC filing ↗
Mar 3, 2026 Jonathan Weinberg F Shares withheld for taxes 8,275 $3.51 $29.0K SEC filing ↗
Mar 3, 2026 Seth Blackley F Shares withheld for taxes 24,053 $3.51 $84.4K SEC filing ↗
Mar 2, 2026 Daniel Joseph McCarthy F Shares withheld for taxes 18,192 $3.58 $65.1K SEC filing ↗
Mar 2, 2026 Daniel Joseph McCarthy A Grant or award 39,281 $0.00 $0 SEC filing ↗
Mar 2, 2026 Jonathan Weinberg A Grant or award 4,910 $0.00 $0 SEC filing ↗
Mar 2, 2026 Jonathan Weinberg F Shares withheld for taxes 1,896 $3.58 $6.8K SEC filing ↗
Mar 2, 2026 Seth Blackley F Shares withheld for taxes 17,736 $3.58 $63.5K SEC filing ↗
Mar 2, 2026 Seth Blackley A Grant or award 58,921 $0.00 $0 SEC filing ↗
Mar 1, 2026 Daniel Joseph McCarthy F Shares withheld for taxes 7,811 $3.25 $25.4K SEC filing ↗
Mar 1, 2026 Jonathan Weinberg F Shares withheld for taxes 4,406 $3.25 $14.3K SEC filing ↗
Mar 1, 2026 Seth Blackley F Shares withheld for taxes 9,537 $3.25 $31.0K SEC filing ↗
Jan 2, 2026 Mario Ramos A Grant or award 587,500 $0.00 $0 SEC filing ↗
Jul 1, 2025 Daniel Joseph McCarthy A Grant or award 44,767 $0.00 $0 SEC filing ↗
Jul 1, 2025 John Paul Johnson A Grant or award 25,461 $0.00 $0 SEC filing ↗
Jul 1, 2025 Jonathan Weinberg A Grant or award 23,394 $0.00 $0 SEC filing ↗
Jul 1, 2025 Seth Blackley A Grant or award 67,150 $0.00 $0 SEC filing ↗

From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.

What a Form 4 is

The report an officer, director or large shareholder must file after trading their own company’s stock.

Subsidiaries — 6 legal entities

Subsidiaries of Evolent Health, Inc.

6 legal entities named in the subsidiary exhibit filed with this company’s most recent 10-K. . Filing on SEC.gov.

This is not the full list. SEC rules only require a company to name its significant subsidiaries.

What that leaves out

Smaller entities are left out of the exhibit entirely. A short list here means a short exhibit — it does not mean the company owns nothing else. Nothing on this page is inferred: every name below is copied from the filing.

Subsidiaries Evolent Health, Inc. names in its most recent annual report, with the place each one is organised.
Subsidiary Organised in
EH Holding Company, Inc. Delaware
Evolent Health International Philippines, Inc. Philippines
Evolent Health International Private Ltd. India
Evolent Health LLC Delaware
Evolent IPA of New York, Inc. New York
Evolent Specialty Services, Inc. Delaware
What counts as a subsidiary

A subsidiary is a separate legal entity this company controls; it is not the same thing as a brand, a division or an office. These entities do not file with the SEC in their own right, so there is no separate page to open for them.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Sources and technical notes

Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.

Share count: cover page of the latest filing (dei:EntityCommonStockSharesOutstanding), taken from Evolent Health, Inc.’s own filings and multiplied by our closing price. Full method.

What that share count means

the share count the company itself prints on the cover of its most recent filing, as of the date it signed that filing.

We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from Evolent Health, Inc.’s own SEC filings multiplied by the closing price we hold for the same stock.